ADXS-504

N/A

Report date: 2022/07/05 11:29:45

Base Information

Drug NameADXS-504
Drug Alias NameADXS-504
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionT lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAyala Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOS Therapies IncColumbia University
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A